Mapping cell behaviors in high-grade glioma to improve treatment
The researchers profiled 313 tumor biopsies from 68 high-grade glioma (HGG) patients. This image is a representation of the 3-dimensional relationship of multiple tissue biopsies from a single patient ’s HGG tumor. The different colors depict different versions of genetic mutations relative to the epidermal growth factor receptor gene. High-grade gliomas are cancerous tumors that spread quickly in the brain or spinal cord. In a new study led by Mayo Clinic, researchers found invasive brain tumo r… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - November 10, 2023 Category: Databases & Libraries Source Type: news
Day One Announces FDA Acceptance of NDA and Priority Review for Tovorafenib in Relapsed or Progressive Pediatric Low-Grade Glioma (pLGG)
BRISBANE, Calif., Oct. 30, 2023 (GLOBE NEWSWIRE) -- Day One Biopharmaceuticals (Nasdaq: DAWN) (“Day One” or the“Company”), a clinical-stage biopharmaceutical company dedicated to developing and commercializing targeted... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - October 30, 2023 Category: Drugs & Pharmacology Source Type: news
Imaging Biometrics touts IB Neuro study
Advanced visualization software firm Imaging Biometrics highlighted a study featuring its IB Neuro software for assessing brain tumors.IB Neuro performs quantitative analysis of MRI dynamic susceptibility contrast (DSC) studies, a common perfusion MRI exam for evaluating brain tumors, according to the vendor.In the study, published September 28 in Nature Communications, researchers at the Mayo Clinic in Arizona obtained multiple biopsies from different regions of tumors in patients with high-grade gliomas. They recorded the precise location of each biopsy using stereotactic coordinates.Then, each biopsy sample was matched ...
Source: AuntMinnie.com Headlines - October 18, 2023 Category: Radiology Authors: AuntMinnie.com staff writers Tags: Industry News Source Type: news
Attend the symposium virtually to hear the latest updates on adult diffuse IDH mutant gliomas. Attend the symposium virtually to hear the latest updates on adult diffuse IDH mutant gliomas.
Six expert faculty discuss various aspects of the evolving data for IDH mutation inhibition in patients with adult diffuse gliomas.Medscape Medical Affairs (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 9, 2023 Category: Consumer Health News Tags: None Virtual Symposium Source Type: news
Case of frontal glioma with a factitious disorder of self-inflicting dental injuries managed by coronally advanced flap with orthodontic buttons - Pattnaik A, Pattnaik N, Das M, Dash D.
Factitious disorders represent deliberately fabricated dissimulation of physical and psychological signs and symptoms seeking medical attention by the patient. Usually, they are ignorant of conventional treatment and consistently change their version of si... (Source: SafetyLit)
Source: SafetyLit - September 25, 2023 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news
Dabrafenib, Trametinib Active in Pediatric Glioma With BRAF V600
THURSDAY, Sept. 21, 2023 -- Dabrafenib plus trametinib results in significantly more responses and longer progression-free survival than standard chemotherapy for pediatric patients with low-grade glioma with BRAF V600 mutations, according to a... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 21, 2023 Category: Pharmaceuticals Source Type: news
Epigenetic Marks May Cause Brain Tumor Formation
Scientists established an epigenetic mouse model for glioma, providing insight into how epigenetics can initiate cancer. (Source: The Scientist)
Source: The Scientist - September 19, 2023 Category: Science Tags: News News & Opinion Source Type: news
Day One Announces Updated FIREFLY-1 Data for Tovorafenib and Completion of Rolling NDA Submission to FDA for Relapsed or Progressive Pediatric Low-Grade Glioma (pLGG)
Overall response rate (ORR) greater than 50% across three assessment criteria
Median duration of tovorafenib treatment of 15.8 months as of June 5, 2023, with 66% of patients remaining on treatment
FDA filing decision expected by... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - September 11, 2023 Category: Drugs & Pharmacology Source Type: news
Microdevices for Glioma; Cervical Adenocarcinoma Test; Language Gaps and Cancer Care
(MedPage Today) -- An intratumoral drug-releasing microdevice implanted in glioma patients can measure the drug's antitumor effects and could potentially help guide treatment, early data suggest. (Brigham and Women's Hospital, Science Translational... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - September 7, 2023 Category: Hematology Source Type: news
Faye Fantarrow Dies: British Singer-Songwriter Mentored By Eurythmics ’ Dave Stewart Was 21
Faye Fantarrow, the British singer-songwriter mentored and produced by Eurythmics co-founder Dave Stewart, died at her home Saturday a year after being diagnosed with the aggressive and rare brain tumor known as glioma. She was 21. Fantarrow’s death was announced by her mother Pam Fantarrow and on…#fayefantarrow #eurythmics #davestewart #fantarrow #pamfantarrow #faye #mumpam #sunderland #weekend #ep (Source: Reuters: Health)
Source: Reuters: Health - September 1, 2023 Category: Consumer Health News Source Type: news
An Overview of the INDIGO data in French, German, Italian and Spanish An Overview of the INDIGO data in French, German, Italian and Spanish
Vorasidenib is the first targeted therapy with positive pivotal phase 3 data in patients with grade 2 IDH1/2-mutant diffuse glioma. The INDIGO study met primary and key secondary endpoints in the second interim analysis.Medscape Medical Affairs (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 1, 2023 Category: Consumer Health News Tags: None Virtual Symposium Source Type: news
AI could help evaluate brain tumors on PET
A group in Germany has developed an AI model for PET imaging that could hel...Read more on AuntMinnie.comRelated Reading:
PET imaging effective for guiding treatment of pediatric brain cancer
FET-PET offers more info on treatment of brain metastases
FET-PET can be useful for glioma evaluations
FET-PET adds 'relevant' info to pediatric cancer cases
SNMMI: FET-PET could have answers for brainstem glioma (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 15, 2023 Category: Radiology Source Type: news
Palliative Radiation Therapy Improves QoL in HG Glioma Palliative Radiation Therapy Improves QoL in HG Glioma
Quality of life improves or at least remains stable for 3 months following short-course radiation therapy over 2 weeks in patients with high-grade gliomas.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 24, 2023 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
How my boy's eye 'wobbling' ended up being a BRAIN TUMOUR: Mother shares shock symptom that left her 11-year-old visually impaired
Zac, left visually-impaired by his optic nerve glioma, is currently enrolled in a trial of a 'life-changing' drug, which he has been taking since he was five. (Source: the Mail online | Health)
Source: the Mail online | Health - July 20, 2023 Category: Consumer Health News Source Type: news
AI Tool Allows Identification of Malignant Cells in Gliomas
THURSDAY, July 13, 2023 -- An artificial intelligence system can identify cancer cells and predict genetic mutation status of gliomas using intraoperative cryosection samples, according to a study published online July 7 in Med.
Noting that... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 13, 2023 Category: Pharmaceuticals Source Type: news
